Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a nn » a non (Expand Search), a n (Expand Search), _ nn (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a nn » a non (Expand Search), a n (Expand Search), _ nn (Expand Search)
-
8341
A Practical, Fast, and High-Yielding Aziridination Procedure Using Simple Cu(II) Complexes Containing N-Donor Pyridine-Based Ligands
Published 2005“…<i>Four-coordinate</i> dichlorocopper(II) complexes derived from di(2-pyridyl)methanes or pyridine itself exhibit high catalytic activity in aziridination of regular olefins with PhINTs in weakly coordinating chloroform in the presence of 1−2 equiv of NaBAr<sup>F</sup><sub>4</sub> (BAr<sup>F</sup><sub>4</sub><sup>-</sup> = tetra[3,5-di(trifluoromethyl)phenyl]borate). High yields of aziridines exceeding 90% can be obtained with a 1:1 olefin/PhINTs ratio and 1−5 mol % catalyst loading for such reactive olefins as styrene, tri- and tetramethylethylene. …”
-
8342
A Practical, Fast, and High-Yielding Aziridination Procedure Using Simple Cu(II) Complexes Containing N-Donor Pyridine-Based Ligands
Published 2005“…<i>Four-coordinate</i> dichlorocopper(II) complexes derived from di(2-pyridyl)methanes or pyridine itself exhibit high catalytic activity in aziridination of regular olefins with PhINTs in weakly coordinating chloroform in the presence of 1−2 equiv of NaBAr<sup>F</sup><sub>4</sub> (BAr<sup>F</sup><sub>4</sub><sup>-</sup> = tetra[3,5-di(trifluoromethyl)phenyl]borate). High yields of aziridines exceeding 90% can be obtained with a 1:1 olefin/PhINTs ratio and 1−5 mol % catalyst loading for such reactive olefins as styrene, tri- and tetramethylethylene. …”
-
8343
-
8344
-
8345
-
8346
GBE did not modify cell morphology but decreased reactive oxygen species (ROS) levels.
Published 2010“…<b>D</b>) ROS levels (DHR fluorescence units/1×10<sup>5</sup> cells normalized to the respective untreated control and APP cells = 100%) were significantly decreased after treatment with GBE (100 µg/ml; 24 h). …”
-
8347
-
8348
Cell Migration in Pulsed Directional Current Fields, Constant Electric Fields of Decreasing Intensity or an Anion-exchange Membrane Between an Agar Bridge and a Platinum Electrode.
Published 2015“…(A) and (B) are pulse direction waveforms of 50% and 75% duty cycles in a 5 V/cm field. …”
-
8349
-
8350
-
8351
<i>Igfbp7</i> expression is substantially decreased during involution in the mammary gland.
Published 2014“…<p>(A) To ascertain if expression of <i>Igfbp7</i> correlates with involution, protein extracts were prepared from the Wild Type glands on the lactation day 3 (WT LD3) or involuting WT glands (weaned for 5 days, WT Inv D5) and the expression of <i>Igfbp7</i> protein was examined using Western blots. …”
-
8352
-
8353
-
8354
JWH-018 and M1 decreased mouse locomotor activity in a CB1R-dependent manner, similar to Δ<sup>9</sup>-THC.
Published 2013“…<p><b>A.</b> Intraperitoneal (i.p.) administration of 3 mg/kg JWH-018, 10 mg/kg JWH-018 M1, and 30 mg/kg Δ<sup>9</sup>-THC decreased locomotor activity relative to vehicle controls over a 10 h time course, beginning 60 min after injection. …”
-
8355
-
8356
Gizzard erosions in broiler chickens in Sweden caused by fowl adenovirus serotype 1 (FAdV-1): investigation of outbreaks, including whole-genome sequencing of an isolate
Published 2022“…All five flocks had a history of decreased growth and uneven size of birds since 9-10 days of age. …”
-
8357
-
8358
Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera
Published 2023“…After the discovery of a mutation in the Janus kinase 2 (<i>JAK</i>2<sup>V617F</sup>), JAK2 inhibitors have been tested as second-line therapies. …”
-
8359
-
8360